OpenURL Connection Search

Select item for more details and to access through your institution.

A study of fetal macrosomia.
Published in:
Archives of Gynecology & Obstetrics, 2000, v. 263, n. 1/2, p. 51
By:
- Wollschlaeger, Kerstin;
- Nieder, Jürgen;
- Köppe, Ingrid;
- Härtlein, Katrin
Publication type:
Article
Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2006, v. 13, n. 12, p. 1702, doi. 10.1245/s10434-006-9058-0
By:
- Harter, Philipp;
- Bois, Andreas;
- Hahmann, Maik;
- Hasenburg, Annette;
- Burges, Alexander;
- Loibl, Sibylle;
- Gropp, Martina;
- Huober, Jens;
- Fink, Daniel;
- Schröder, Willibald;
- Muenstedt, Karsten;
- Schmalfeldt, Barbara;
- Emons, Guenter;
- Pfisterer, Jacobus;
- Wollschlaeger, Kerstin;
- Meerpohl, Hans-Gerd;
- Breitbach, Georg-Peter;
- Tanner, Berno;
- Sehouli, Jalid
Publication type:
Article
The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients.
Published in:
British Journal of Clinical Pharmacology, 2015, v. 80, n. 5, p. 1139, doi. 10.1111/bcp.12688
By:
- Bachmann, Hagen Sjard;
- Meier, Werner;
- Bois, Andreas;
- Kimmig, Rainer;
- Kuhlmann, Jan Dominik;
- Siffert, Winfried;
- Sehouli, Jalid;
- Wollschlaeger, Kerstin;
- Huober, Jens;
- Hillemanns, Peter;
- Burges, Alexander;
- Schmalfeldt, Barbara;
- Aminossadati, Behnaz;
- Wimberger, Pauline
Publication type:
Article
Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group.
Published in:
Breast Cancer Research & Treatment, 2013, v. 139, n. 3, p. 779, doi. 10.1007/s10549-013-2589-8
By:
- Lück, Hans-Joachim;
- Bois, Andreas;
- Loibl, Sibylle;
- Schrader, Iris;
- Huober, Jens;
- Heilmann, Volker;
- Beckmann, Matthias;
- Stähler, Ann;
- Jackisch, Christian;
- Hubalek, Michael;
- Richter, Barbara;
- Stickeler, Elmar;
- Eidtmann, Holger;
- Thomssen, Christoph;
- Untch, Michael;
- Wollschläger, Kerstin;
- Schuster, Tibor;
- Minckwitz, Gunter
Publication type:
Article
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era.
Published in:
2022
By:
- You, Benoit;
- Van Wagensveld, Lilian;
- Tod, Michel;
- Sonke, Gabe S.;
- Horlings, Hugo M.;
- Kruitwagen, R. F. P. M.;
- Du Bois, Andreas;
- Selle, Frédéric;
- Perren, Timothy;
- Pfisterer, Jacobus;
- Joly, Florence;
- Cook, Adrian;
- Kaminsky, Marie Christine;
- Wollschlaeger, Kerstin;
- Lortholary, Alain;
- Tome, Oliver;
- Leary, Alexandra;
- Freyer, Gilles;
- Van Der Aa, Maaike;
- Colomban, Olivier
Publication type:
journal article

Found: 5

A study of fetal macrosomia.

Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial.

The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients.

Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group.

Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era.